Header Logo

Payal Gurnani

Concepts (46)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacists
2
2021
16
0.870
Why?
Marfan Syndrome
1
2018
4
0.580
Why?
Drug-Eluting Stents
1
2018
15
0.580
Why?
Extracorporeal Membrane Oxygenation
1
2018
22
0.570
Why?
Fluid Therapy
1
2010
25
0.330
Why?
Shock, Septic
1
2010
59
0.330
Why?
Practice Guidelines as Topic
1
2010
252
0.300
Why?
Anti-Bacterial Agents
1
2010
367
0.270
Why?
Professional Role
2
2021
28
0.210
Why?
Epoprostenol
1
2021
6
0.180
Why?
Pulmonary Ventilation
1
2021
9
0.180
Why?
Nebulizers and Vaporizers
1
2021
21
0.180
Why?
Antihypertensive Agents
1
2021
46
0.180
Why?
Hypercalcemia
1
2020
7
0.170
Why?
Calcitonin
1
2020
14
0.170
Why?
Diphosphonates
1
2020
15
0.170
Why?
Intubation, Intratracheal
1
2021
87
0.170
Why?
Critical Care
1
2021
113
0.160
Why?
Patient Care Team
1
2021
110
0.160
Why?
Pandemics
1
2021
211
0.160
Why?
Neoplasms
1
2020
230
0.140
Why?
Intensive Care Units
1
2019
248
0.130
Why?
Humans
6
2021
25967
0.130
Why?
Emergency Service, Hospital
1
2019
254
0.120
Why?
Adult
3
2021
7662
0.120
Why?
Male
4
2021
14277
0.100
Why?
Resuscitation
1
2010
11
0.080
Why?
Clinical Protocols
1
2010
57
0.080
Why?
Hospital Mortality
1
2010
134
0.080
Why?
Evidence-Based Medicine
1
2010
160
0.080
Why?
Multivariate Analysis
1
2010
326
0.080
Why?
Middle Aged
3
2021
8772
0.070
Why?
Aged
3
2021
8732
0.070
Why?
Cross Infection
1
2010
297
0.070
Why?
Time Factors
1
2010
1391
0.060
Why?
Prospective Studies
1
2010
1701
0.060
Why?
Female
3
2021
14734
0.050
Why?
Retrospective Studies
2
2021
3358
0.050
Why?
Reagent Kits, Diagnostic
1
2021
6
0.050
Why?
Treatment Outcome
1
2010
3399
0.050
Why?
Administration, Inhalation
1
2021
37
0.050
Why?
Dose-Response Relationship, Drug
1
2021
328
0.040
Why?
Case-Control Studies
1
2021
571
0.040
Why?
Pharmacy Service, Hospital
1
2019
11
0.040
Why?
Cost Savings
1
2019
31
0.040
Why?
Critical Illness
1
2019
110
0.040
Why?
Gurnani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (46)
Explore
_
Co-Authors (6)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_